Megan Burke

Challenges in the recruitment of adolescents and young adults to cancer clinical trials

N. Marina, K. Albritton, Megan Burke, 2007, Cancer.

Assessment of response to induction therapy and its influence on 5-year failure-free survival in group III rhabdomyosarcoma: the Intergroup Rhabdomyosarcoma Study-IV experience--a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.

James R. Anderson, D. Rodeberg, W. Meyer, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Does body mass index at diagnosis or weight change during therapy predict toxicity or survival in intermediate risk rhabdomyosarcoma? A report from the Children's Oncology Group soft tissue sarcoma committee

J. Meza, E. Lyden, C. Arndt, 2013, Pediatric blood & cancer.

Assessment of multiple-opinion referrals and consults at the BC Children’s Hospital Allergy Clinic

E. Chan, Adam P Sage, Megan Burke, 2023, Allergy, Asthma & Clinical Immunology.

Should we continue to counsel families to use hydrolyzed formulas as a means of allergy prevention in high-risk infants?

E. Chan, E. Abrams, Megan Burke, 2019, Paediatrics & child health.

Investigating Metal Cations as Potential Inhibitors of IAPP Aggregation: KCl, CaCl2, and CuCl2

Megan Burke, 2016 .

Does body mass index at diagnosis or weight change during therapy predict toxicity or survival in intermediate risk rhabdomyosarcoma? A report from the Children's Oncology Group soft tissue sarcoma committee

J. Meza, E. Lyden, C. Arndt, 2013, Pediatric blood & cancer.